BETA


2011/2193(INI) Voluntary and unpaid donation of tissues and cells

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead ENVI YANNAKOUDAKIS Marina (icon: ECR ECR) LIESE Peter (icon: PPE PPE), PRODI Vittorio (icon: S&D S&D), RIES Frédérique (icon: ALDE ALDE), AUKEN Margrete (icon: Verts/ALE Verts/ALE), MATIAS Marisa (icon: GUE/NGL GUE/NGL)
Committee Opinion IMCO
Committee Opinion JURI
Committee Opinion ITRE MAŠTÁLKA Jiří (icon: GUE/NGL GUE/NGL)
Lead committee dossier:
Legal Basis:
RoP 052

Events

2012/12/19
   EC - Commission response to text adopted in plenary
Documents
2012/09/11
   EP - Results of vote in Parliament
2012/09/11
   EP - Decision by Parliament, 1st reading/single reading
Details

The European Parliament adopted by 551 votes to 15, with 81 abstentions, a resolution on voluntary and unpaid donation of tissues and cells in response to the Second Report from the Commission on the subject.

It notes with concern that half of Member States state that they regularly face a lack of human tissues and cells , particularly spinal marrow, gametes and tissues such as corneas and skin; believes that the policies and laws in force should therefore be reviewed, as they are not adequate to meet the challenge of self-sufficiency in the EU. Members recall that while 11 countries have official policies in place to endeavour to promote self-sufficiency of tissues and cells, 17 other countries have bilateral agreements with the same aim of ensuring national supplies of human tissues and cells.

Non-remuneration, consent and safeguarding health: the resolution states that the removal of tissue and cells must be subject to the following principles: anonymity (except in the case of removal from a living person for a relative), non-remuneration, consent, the obligation to share organs for transplant fairly among patients, and safeguarding the health of donors and recipients.

Parliament calls on Member States to adopt protective measures for living donors and to guarantee that donation is anonymous (except in the case of procurement from a living person for a relative), voluntary, freely agreed to, informed and not remunerated.

It calls on the Commission to

report on current national practices and criteria for compensation of living donors, especially as regards egg cell donation; carefully monitor developments in the Member States, to examine carefully any reports from civil society or in the media about violation of the principle of unpaid donation , and to take appropriate action, including, if necessary, infringement proceedings.

Member States are asked to clearly define the conditions under which fair and proportionate financial compensation may be granted, bearing in mind that compensation is strictly limited to conditions making good the expenses incurred in donating tissues and cells, such as travel expenses, loss of earnings or medical costs related to the medical procedure and possible side effects, thereby prohibiting any financial incentives and avoiding disadvantages for a potential donor. Such compensations must be transparent and regularly audited.

Any compensation provided to donors must be compatible with ethical principles. The committee advises that particular attention should be paid to this issue where the compensation is given not to the donor, but to the donor’s family after death . Four countries provide forms of compensation or incentives to relatives of deceased donors.

Anonymity, traceability, transparency and information: Parliament calls on all Member States to:

set up rules for ensuring the traceability of tissues and cells of human origin from donor to patient and vice versa, as well as a system for the regulation of imports of human tissues and cells from third countries, ensuring that equivalent standards of quality and safety will apply. step up their public information and awareness-raising campaigns to promote the donation of tissues and cells and to ensure the provision of medical information that is clear, fair, scientifically based and conclusive and of data enabling the public to make informed choices; take coordinated actions to prevent the development of a black market in gametes on the Internet, as such a market risks both undermining the quality and safety of tissues and cells and raises legal, ethical and public health problems.

Exchanging best practice and reinforcing European and international cooperation: Parliament calls on Member States to step up exchanges of good practices, particularly with regard to the supply of tissues and cells, the protection of the quality of tissues and cells while they are being transported, raising awareness of donating and training health staff. The Commission and Member States should consider the possibility of setting up a Europe-wide database of donors and potential recipients in order to manage supply in the general interest and avoid shortages where possible. Members particularly applaud the role in this field of Eurocet, which has played a crucial role in acting as the central European database for the collection of data on tissue and cell donation and transplantation activities. They call on Member State authorities to reinforce their collaboration with Eurocet in order to agree further common standards in the donation of cells and tissues and thereby enable healthcare professionals to improve the matches offered to European citizens.

Cord blood and stem cells: Members recognise the significant scientific advances made in the cord blood field, which is a very promising therapeutic alternative in the treatment of many diseases, including children’s illnesses. They call therefore on the Commission and Member States to take appropriate measures to establish a regulatory framework which could stimulate increased availability of umbilical cord blood stem cells.

Parliament regrets that at present, stem cells from umbilical cord blood are only stored at 1% of total births in the EU. Member States are asked to raise awareness of public cord blood banking through information campaigns that may take place, for example, during antenatal classes, and proposes that in compliance with the provisions of the Charter of Fundamental Rights of the European Union.

Parliament takes the view that donations of non-family allogeneic umbilical cord blood, regardless of whether the bank is public or private, should be further developed, so that stored units of umbilical cord blood are registered in the Bone Marrow Donors Worldwide (BMDW) database and made available to any compatible patient who needs them.

Furthermore, comprehensive, objective and accurate information should be provided about the advantages and disadvantages of cord blood banks. Parliament proposes that Member States consider adopting and enforcing operational and ethical standards for public and private cord blood banks that uphold the principle of non-commercialisation of the human body and its parts, for example, and ensure traceability. It expects all Member States to establish at least one public stem cell bank, and calls for European standards and requirements for private stem cell banks . Member States are further asked to provide a territorial network of maternity centres authorised to carry out this procurement to guarantee cord blood supply in all population centres.

Members note that collaboration models and opportunities between public and private sectors already exist in some Member States, and they encourage public and private cord blood banks to collaborate closely in order to increase the availability and exchange of national, European and international cord blood and tissue samples. They call on Member States to appropriately regulate both public and private banks to guarantee the fullest transparency and safety of cord blood, and also highlight the development of non-intrusive procedures of harvesting stem cells using peripheral blood stem cell collection (PBSC).

Whilst emphasising that it is for the Member States to decide whether to allow, prohibit or regulate research with human embryonic stem cells and in vitro fertilization, Parliament notes that Member States must respect the rules set out in Directive 2004/23/EC. It points out that the EU has limited competence in this area and, when applying this competence, needs to respect the principles of the EU Charter of Fundamental Rights and the principles applied in the judgments of the Court of Justice.

The Commission is asked to:

propose a revision of Directive 2004/23/EC in order to bring it into line with the principles governing organ donation laid down in Directive 2010/45/EU, and to take into account the new legal situation after the entry into force of the Lisbon Treaty, scientific developments, the practical experience of those involved in the sector and the recommendations of this resolution; propose a revision of Regulation (EC) No 1394/2007 in order to include a provision that guarantees the application of the principle of unpaid donation similar to that referred to in Directive 2010/45/EU and to take into account the problems that have occurred in respect of the implementation of the Regulation, especially for SMEs.

Documents
2012/09/11
   EP - End of procedure in Parliament
2012/09/10
   EP - Debate in Parliament
2012/06/29
   EP - Committee report tabled for plenary, single reading
Details

The Committee on the Environment, Public Health and Food Safety adopted the own-initiative report by Marina YANNAKOUDAKIS (ECR, UK) on voluntary and unpaid donation of tissues and cells in response to the Second Report from the Commission on the subject.

It notes with concern that half of Member States state that they regularly face a lack of human tissues and cells, particularly spinal marrow, gametes and tissues such as corneas and skin; believes that the policies and laws in force should therefore be reviewed, as they are not adequate to meet the challenge of self-sufficiency in the European Union. Members recall that while 11 countries have official policies in place to endeavour to promote self-sufficiency of tissues and cells, 17 other countries have bilateral agreements with the same aim of ensuring national supplies of human tissues and cells.

Non-remuneration, consent and safeguarding health : the report states that the removal of tissue and cells must be subject to the following principles: anonymity (except in the case of removal from a living person for a relative), non-remuneration, consent, the obligation to share organs for transplant fairly among patients, and safeguarding the health of donors and recipients.

Members go on to stress that donation should be voluntary, unpaid and anonymous (except in the case of procurement from a living person for a relative), governed by protective legal and ethical rules that respect the integrity of the person. They call on the Commission to

· report on current national practices and criteria for compensation of living donors, especially as regards egg cell donation;

· carefully monitor developments in the Member States, to examine carefully any reports from civil society or in the media about violation of the principle of unpaid donation, and to take appropriate action, including, if necessary, infringement proceedings.

Member States are asked to clearly define the conditions under which fair and proportionate financial compensation may be granted, bearing in mind that compensation is strictly limited to conditions making good the expenses incurred in donating tissues and cells, such as travel expenses, loss of earnings or medical costs related to the medical procedure and possible side effects, thereby prohibiting any financial incentives and avoiding disadvantages for a potential donor. Such compensations must be transparent and regularly audited.

Any compensation provided to donors must be compatible with ethical principles. The committee advises that particular attention should be paid to this issue where the compensation is given not to the donor, but to the donor’s family after death. Four countries provide forms of compensation or incentives to relatives of deceased donors;

Anonymity, traceability, transparency and information: the committee calls on all Member States to:

· set up rules for ensuring the traceability of tissues and cells of human origin from donor to patient and vice versa, as well as a system for the regulation of imports of human tissues and cells from third countries, ensuring that equivalent standards of quality and safety will apply.

· step up their public information and awareness-raising campaigns to promote the donation of tissues and cells and to ensure the provision of medical information that is clear, fair, scientifically based and conclusive and of data enabling the public to make informed choices;

· take coordinated actions to prevent the development of a black market in gametes on the Internet, as such a market risks both undermining the quality and safety of tissues and cells and raises legal, ethical and public health problems.

Exchanging best practice and reinforcing European and international cooperation : the report calls on Member States to step up exchanges of good practices, particularly with regard to the supply of tissues and cells, the protection of the quality of tissues and cells while they are being transported, raising awareness of donating and training health staff. The Commission and Member States should consider the possibility of setting up a Europe-wide database of donors and potential recipients in order to manage supply in the general interest and avoid shortages where possible. Members particularly applaud the role in this field of Eurocet, which has played a crucial role in acting as the central European database for the collection of data on tissue and cell donation and transplantation activities. They call on Member State authorities to reinforce their collaboration with Eurocet in order to agree further common standards in the donation of cells and tissues and thereby enable healthcare professionals to improve the matches offered to European citizens.

Cord blood and stem cells : Members recognise the significant scientific advances made in the cord blood field, which is a very promising therapeutic alternative in the treatment of many diseases, including children’s illnesses. They call therefore on the Commission and Member States to take appropriate measures to establish a regulatory framework which could stimulate increased availability of umbilical cord blood stem cells.

The committee regrets that at present, stem cells from umbilical cord blood are only stored at 1% of total births in the EU. Member States are asked to raise awareness of public cord blood banking through information campaigns that may take place, for example, during antenatal classes, and proposes that in compliance with the provisions of the Charter of Fundamental Rights of the European Union.

Furthermore, comprehensive, objective and accurate information should be provided about the advantages and disadvantages of cord blood banks. The report proposes that Member States consider adopting and enforcing operational and ethical standards for public and private cord blood banks that uphold the principle of non-commercialisation of the human body and its parts, for example, and ensure traceability. It expects all Member States to establish at least one public stem cell bank, and calls for European standards and requirements for private stem cell banks.

Members note that collaboration models and opportunities between public and private sectors already exist in some Member States, and they encourage public and private cord blood banks to collaborate closely in order to increase the availability and exchange of national, European and international cord blood and tissue samples. They call on Member States to appropriately regulate both public and private banks to guarantee the fullest transparency and safety of cord blood, and also highlight the development of non-intrusive procedures of harvesting stem cells using peripheral blood stem cell collection (PBSC).

Whilst emphasising that it is for the Member States to decide whether to allow, prohibit or regulate research with human embryonic stem cells and in vitro fertilization, Member States must respect the rules set out in Directive 2004/23/EC,

The Commission is asked to:

· propose a revision of Directive 2004/23/EC in order to bring it into line with the principles governing organ donation laid down in Directive 2010/45/EU, and to take into account the new legal situation after the entry into force of the Lisbon Treaty, scientific developments, the practical experience of those involved in the sector and the recommendations of this report;

· propose a revision of Regulation (EC) No 1394/2007 in order to include a provision that guarantees the application of the principle of unpaid donation similar to that referred to in Directive 2010/45/EU and to take into account the problems that have occurred in respect of the implementation of the regulation, especially for SMEs.

Documents
2012/06/20
   EP - Vote in committee, 1st reading/single reading
2012/06/07
   EP - Amendments tabled in committee
Documents
2012/05/15
   EP - Amendments tabled in committee
Documents
2012/04/26
   EP - Committee opinion
Documents
2012/03/09
   EP - Committee draft report
Documents
2011/11/21
   EP - MAŠTÁLKA Jiří (GUE/NGL) appointed as rapporteur in ITRE
2011/09/29
   EP - Committee referral announced in Parliament, 1st reading/single reading
2011/09/20
   EP - YANNAKOUDAKIS Marina (ECR) appointed as rapporteur in ENVI
2011/06/17
   EC - Follow-up document
Details

PURPOSE: presentation by the Commission of its Second Report on Voluntary and Unpaid Donation of Tissues and Cells in accordance with Directive 2004/23/EC .

CONTENT: the report is based on the Members States' responses to a report template on voluntary and unpaid donation of tissues and cells. All Member States submitted a report to the Commission. In addition, Liechtenstein and Norway submitted a report (in total 29 reporting countries).

The report aims to provide an overview of the practice of voluntary and unpaid donation of tissues and cells, focusing on (1) legislative provisions, guidelines and policies; (2) compensation and incentives; (3) promotion and advertising, and (4) procurement and supply.

Compliance: the report shows that Member States overall comply with Article 12 of Directive 2004/23/EC, requiring Member States to take the necessary measures to endeavour to ensure voluntary and unpaid donations of tissues and cells. Largely in line with the findings of the first report on voluntary and unpaid donation of tissues and cells (issued in 2006), this report shows that legislative provisions and guidelines on voluntary and unpaid donation of tissues and cells are well established across the EU. 27 out of the 29 reporting countries have such legislative provisions or guidelines in place.

Compensation: 19 of the reporting countries have some form of compensation or incentive structures for donors of tissues and cells (excluding reproductive cells), such as reimbursement of travel and medical costs. For reproductive cells, about half of the countries provide some forms of compensation or incentives, including reimbursement of travel costs, refreshments and compensation linked to loss of earnings. In addition, four countries give some form of compensation or incentives to relatives of deceased donors.

Promotion: 19 countries have undertaken some form of measures to promote voluntary and unpaid donation of tissues and cells, such as awareness raising and information campaigns. In addition, 23 countries have restrictions or prohibitions on advertising the need for, or availability of, human tissues and cells with a view to offering or seeking financial gain or comparable advantage (in line with article 12 of Directive 2004/23/EC).

Procurement and supply of tissues and cells : the report shows that the majority of the countries have public collectors/suppliers or a dual system of public and private collectors/suppliers. With regards to supply, 11 countries report having policies in place to endeavour to promote self-sufficiency of tissues and cells, and 17 countries have bilateral or other forms of agreements/collaboration structures to ensure national supply of tissues and cells. However, almost half of the countries report some form of shortages of tissues and cells, including bone marrow and gametes.

As set out in Article 12 of Directive 2004/23/EC, the Commission shall inform the European Parliament and the Council of any necessary further measures it intends to take in the field of voluntary and unpaid donation of tissues and cells. Based on the findings of this report, the Commission will now, together with the Member States, reflect on the potential need for further measures, keeping in mind that the Commission's legal mandate is limited to quality and safety of tissues and cells.

2011/06/17
   EC - Non-legislative basic document published
Details

The Commission presents its Second Report on Voluntary and Unpaid Donation of Tissues and Cells in accordance with Directive 2004/23/EC . The report is based on the Members States' responses to a report template on voluntary and unpaid donation of tissues and cells. All Member States submitted a report to the Commission. In addition, Liechtenstein and Norway submitted a report (in total 29 reporting countries).

The report aims to provide an overview of the practice of voluntary and unpaid donation of tissues and cells, focusing on 1) legislative provisions, guidelines and policies; 2) compensation and incentives; 3) promotion and advertising, and 4) procurement and supply.

Compliance: the report shows that Member States overall comply with Article 12 of Directive 2004/23/EC, requiring Member States to take the necessary measures to endeavour to ensure voluntary and unpaid donations of tissues and cells. Largely in line with the findings of the first report on voluntary and unpaid donation of tissues and cells (issued in 2006), this report shows that legislative provisions and guidelines on voluntary and unpaid donation of tissues and cells are well established across the EU. 27 out of the 29 reporting countries have such legislative provisions or guidelines in place.

Compensation: 19 of the reporting countries have some form of compensation or incentive structures for donors of tissues and cells (excluding reproductive cells), such as reimbursement of travel and medical costs. For reproductive cells, about half of the countries provide some forms of compensation or incentives, including reimbursement of travel costs, refreshments and compensation linked to loss of earnings. In addition, four countries give some form of compensation or incentives to relatives of deceased donors.

Promotion: 19 countries have undertaken some form of measures to promote voluntary and unpaid donation of tissues and cells, such as awareness raising and information campaigns. In addition, 23 countries have restrictions or prohibitions on advertising the need for, or availability of, human tissues and cells with a view to offering or seeking financial gain or comparable advantage (in line with article 12 of Directive 2004/23/EC).

Procurement and supply of tissues and cells : the report shows that the majority of the countries have public collectors/suppliers or a dual system of public and private collectors/suppliers. With regards to supply, 11 countries report having policies in place to endeavour to promote self-sufficiency of tissues and cells, and 17 countries have bilateral or other forms of agreements/collaboration structures to ensure national supply of tissues and cells. However, almost half of the countries report some form of shortages of tissues and cells, including bone marrow and gametes.

As set out in Article 12 of Directive 2004/23/EC, the Commission shall inform the European Parliament and the Council of any necessary further measures it intends to take in the field of voluntary and unpaid donation of tissues and cells. Based on the findings of this report, the Commission will now, together with the Member States, reflect on the potential need for further measures, keeping in mind that the Commission's legal mandate is limited to quality and safety of tissues and cells.

Documents

Votes

A7-0223/2012 - Marina Yannakoudakis - § 43/1 #

2012/09/11 Outcome: +: 637, 0: 13, -: 5
DE IT FR GB ES PL RO CZ BE EL SE HU PT BG AT NL DK FI SK IE LT SI LV LU CY EE MT ??
Total
96
62
64
54
45
39
30
22
21
20
19
20
18
16
16
21
13
12
11
8
8
8
9
6
6
4
4
3
icon: PPE PPE
243

Czechia PPE

2

Denmark PPE

For (1)

1

Ireland PPE

For (1)

1

Luxembourg PPE

3
2

Estonia PPE

For (1)

1

Malta PPE

For (1)

1
icon: S&D S&D
169

Bulgaria S&D

3

Netherlands S&D

2

Finland S&D

2

Slovenia S&D

2

Latvia S&D

1

Luxembourg S&D

For (1)

1

Estonia S&D

For (1)

1
icon: ALDE ALDE
71

Spain ALDE

1

Greece ALDE

1

Sweden ALDE

3
3

Ireland ALDE

3

Lithuania ALDE

1

Slovenia ALDE

2

Latvia ALDE

For (1)

1

Luxembourg ALDE

For (1)

1

Estonia ALDE

1
icon: Verts/ALE Verts/ALE
55

United Kingdom Verts/ALE

5

Spain Verts/ALE

2

Greece Verts/ALE

1

Portugal Verts/ALE

For (1)

1

Austria Verts/ALE

2

Netherlands Verts/ALE

2

Denmark Verts/ALE

2

Finland Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Estonia Verts/ALE

For (1)

1
icon: ECR ECR
41

Belgium ECR

For (1)

1

Hungary ECR

For (1)

1

Netherlands ECR

For (1)

1

Denmark ECR

For (1)

1

Latvia ECR

For (1)

1
icon: GUE/NGL GUE/NGL
32

United Kingdom GUE/NGL

1

Spain GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Netherlands GUE/NGL

1

Denmark GUE/NGL

1

Ireland GUE/NGL

For (1)

1

Latvia GUE/NGL

Against (1)

1
icon: EFD EFD
24

France EFD

Against (1)

1
2

Belgium EFD

For (1)

1

Greece EFD

2

Netherlands EFD

For (1)

1

Denmark EFD

1

Finland EFD

For (1)

1

Slovakia EFD

For (1)

1

Lithuania EFD

For (1)

1
icon: NI NI
20

France NI

Abstain (1)

1

United Kingdom NI

For (1)

3

Spain NI

1

Romania NI

2

Belgium NI

Abstain (1)

1

Hungary NI

For (1)

Abstain (1)

2

Bulgaria NI

2
4

A7-0223/2012 - Marina Yannakoudakis - § 43/2 #

2012/09/11 Outcome: +: 385, -: 231, 0: 17
PL DE FR IT HU PT AT LV CZ CY LU SK ?? IE ES BG FI SE NL BE EL MT SI EE LT GB RO DK
Total
39
93
61
57
20
18
16
8
20
6
6
11
3
8
44
16
10
19
21
21
21
4
7
4
5
53
30
12
icon: PPE PPE
236

Czechia PPE

For (1)

1
2

Luxembourg PPE

3

Ireland PPE

For (1)

1

Malta PPE

For (1)

1

Estonia PPE

For (1)

1

Lithuania PPE

1

Denmark PPE

For (1)

1
icon: Verts/ALE Verts/ALE
53

Portugal Verts/ALE

For (1)

1

Austria Verts/ALE

2

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Spain Verts/ALE

2

Netherlands Verts/ALE

2

Greece Verts/ALE

1

Estonia Verts/ALE

For (1)

1

United Kingdom Verts/ALE

5

Denmark Verts/ALE

2
icon: GUE/NGL GUE/NGL
30

Latvia GUE/NGL

Abstain (1)

1

Ireland GUE/NGL

For (1)

1

Spain GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Netherlands GUE/NGL

1

United Kingdom GUE/NGL

1
icon: ECR ECR
39

Hungary ECR

For (1)

1

Latvia ECR

For (1)

1

Netherlands ECR

For (1)

1

Belgium ECR

For (1)

1

Denmark ECR

Against (1)

1
icon: EFD EFD
24

Slovakia EFD

For (1)

1

Finland EFD

Abstain (1)

1

Netherlands EFD

For (1)

1

Belgium EFD

For (1)

1

Greece EFD

Against (1)

Abstain (1)

2

Lithuania EFD

For (1)

1

Denmark EFD

1
icon: NI NI
21

France NI

2

Hungary NI

For (1)

Abstain (1)

2

Spain NI

1

Bulgaria NI

2
4

Belgium NI

Abstain (1)

1

United Kingdom NI

For (1)

3

Romania NI

Against (1)

2
icon: ALDE ALDE
66

Luxembourg ALDE

Against (1)

1

Ireland ALDE

3

Spain ALDE

1

Finland ALDE

For (1)

3

Sweden ALDE

3

Greece ALDE

Against (1)

1

Slovenia ALDE

Against (1)

Abstain (1)

2

Estonia ALDE

1

Lithuania ALDE

Against (1)

1

Denmark ALDE

3
icon: S&D S&D
164

Latvia S&D

Against (1)

1

Cyprus S&D

Against (1)

2

Luxembourg S&D

For (1)

1

Ireland S&D

3

Bulgaria S&D

3

Finland S&D

2

Netherlands S&D

2

Malta S&D

3

Slovenia S&D

2

Estonia S&D

Against (1)

1

Lithuania S&D

2

A7-0223/2012 - Marina Yannakoudakis - § 43/3 #

2012/09/11 Outcome: +: 390, -: 230, 0: 14
PL DE FR IT HU AT CZ PT GB LV SK ?? IE FI ES BG LU SE CY SI NL BE EE DK EL LT RO MT
Total
40
94
61
60
18
16
20
18
51
8
11
3
8
11
44
16
6
19
5
8
21
19
4
13
19
7
30
4
icon: PPE PPE
237

Czechia PPE

2

Ireland PPE

For (1)

1

Luxembourg PPE

3
2

Estonia PPE

For (1)

1

Denmark PPE

For (1)

1

Malta PPE

For (1)

1
icon: Verts/ALE Verts/ALE
55

Austria Verts/ALE

2

Portugal Verts/ALE

For (1)

1

United Kingdom Verts/ALE

5

Latvia Verts/ALE

1

Finland Verts/ALE

For (1)

1

Spain Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Netherlands Verts/ALE

2

Belgium Verts/ALE

3

Estonia Verts/ALE

For (1)

1

Denmark Verts/ALE

2

Greece Verts/ALE

1
icon: ECR ECR
38

Hungary ECR

For (1)

1

Latvia ECR

For (1)

1

Netherlands ECR

For (1)

1

Belgium ECR

For (1)

1

Denmark ECR

For (1)

1
icon: GUE/NGL GUE/NGL
30

United Kingdom GUE/NGL

1

Latvia GUE/NGL

Abstain (1)

1

Ireland GUE/NGL

For (1)

1

Spain GUE/NGL

For (1)

1

Sweden GUE/NGL

1

Cyprus GUE/NGL

1

Netherlands GUE/NGL

1

Denmark GUE/NGL

1
icon: EFD EFD
22

Slovakia EFD

For (1)

1

Finland EFD

Abstain (1)

1

Netherlands EFD

For (1)

1

Belgium EFD

For (1)

1

Denmark EFD

1

Greece EFD

Against (1)

1
icon: NI NI
19

France NI

For (1)

1

Hungary NI

For (1)

1

United Kingdom NI

For (1)

3

Spain NI

1

Bulgaria NI

2
4

Belgium NI

Abstain (1)

1

Romania NI

Against (1)

2
icon: ALDE ALDE
67

Latvia ALDE

Against (1)

1

Ireland ALDE

3

Finland ALDE

For (1)

3

Spain ALDE

1

Luxembourg ALDE

Against (1)

1

Sweden ALDE

3

Slovenia ALDE

Against (1)

Abstain (1)

2

Estonia ALDE

1

Denmark ALDE

3

Greece ALDE

Against (1)

1

Lithuania ALDE

Against (1)

1
icon: S&D S&D
166

Latvia S&D

Against (1)

1

Ireland S&D

3

Finland S&D

2

Bulgaria S&D

3

Luxembourg S&D

Against (1)

1
2

Slovenia S&D

2

Netherlands S&D

2

Estonia S&D

Against (1)

1

Malta S&D

3

A7-0223/2012 - Marina Yannakoudakis - § 43/4 #

2012/09/11 Outcome: +: 566, -: 66, 0: 15
DE IT FR PL ES GB RO CZ HU EL PT AT SE SK IE BE BG DK LV LT CY SI NL LU MT FI ?? EE
Total
95
62
60
42
44
53
31
21
20
20
18
16
19
11
8
19
16
13
9
8
6
8
21
6
4
10
3
4
icon: PPE PPE
244

Czechia PPE

2

Ireland PPE

For (1)

1

Denmark PPE

For (1)

1
2

Luxembourg PPE

3

Malta PPE

For (1)

1

Estonia PPE

For (1)

1
icon: S&D S&D
166

Bulgaria S&D

3

Latvia S&D

1

Slovenia S&D

2

Netherlands S&D

2

Luxembourg S&D

For (1)

1

Finland S&D

2

Estonia S&D

For (1)

1
icon: Verts/ALE Verts/ALE
53

Spain Verts/ALE

2

United Kingdom Verts/ALE

5

Greece Verts/ALE

1

Portugal Verts/ALE

For (1)

1

Austria Verts/ALE

2

Belgium Verts/ALE

3

Denmark Verts/ALE

2

Latvia Verts/ALE

1

Netherlands Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Estonia Verts/ALE

For (1)

1
icon: ECR ECR
41

Hungary ECR

For (1)

1

Belgium ECR

For (1)

1

Denmark ECR

For (1)

1

Latvia ECR

For (1)

1

Netherlands ECR

For (1)

1
icon: GUE/NGL GUE/NGL
30

France GUE/NGL

2

Spain GUE/NGL

For (1)

1

United Kingdom GUE/NGL

1

Sweden GUE/NGL

1

Ireland GUE/NGL

For (1)

1

Denmark GUE/NGL

1

Latvia GUE/NGL

Abstain (1)

1

Netherlands GUE/NGL

1
icon: EFD EFD
24

France EFD

Against (1)

1

Greece EFD

For (1)

1

Slovakia EFD

For (1)

1

Belgium EFD

For (1)

1

Denmark EFD

1

Lithuania EFD

For (1)

1

Netherlands EFD

For (1)

1

Finland EFD

Abstain (1)

1
icon: NI NI
20

France NI

Abstain (1)

1

Spain NI

1

United Kingdom NI

For (1)

3

Romania NI

2

Hungary NI

2

Belgium NI

Abstain (1)

1

Bulgaria NI

2
4
icon: ALDE ALDE
69

Spain ALDE

1

Greece ALDE

Against (1)

1

Sweden ALDE

3

Ireland ALDE

3

Denmark ALDE

3

Latvia ALDE

Against (1)

1

Lithuania ALDE

Against (1)

1

Slovenia ALDE

Against (1)

Abstain (1)

2

Luxembourg ALDE

Against (1)

1

Estonia ALDE

1

A7-0223/2012 - Marina Yannakoudakis - Résolution #

2012/09/11 Outcome: +: 551, 0: 81, -: 15
DE FR IT ES PL GB RO HU CZ EL BE AT PT SE SK BG FI DK IE SI NL LV LT LU MT CY ?? EE
Total
96
60
59
44
41
55
30
20
21
21
20
17
18
19
11
16
11
13
8
8
20
9
8
6
4
5
3
4
icon: PPE PPE
241

Czechia PPE

2

Denmark PPE

For (1)

1

Ireland PPE

For (1)

1

Luxembourg PPE

3

Malta PPE

For (1)

1
2

Estonia PPE

For (1)

1
icon: S&D S&D
165

Bulgaria S&D

3

Finland S&D

2

Slovenia S&D

2

Netherlands S&D

2

Latvia S&D

1

Luxembourg S&D

For (1)

1

Estonia S&D

For (1)

1
icon: Verts/ALE Verts/ALE
55

Spain Verts/ALE

2

United Kingdom Verts/ALE

5

Greece Verts/ALE

1

Belgium Verts/ALE

Abstain (1)

4

Austria Verts/ALE

2

Portugal Verts/ALE

For (1)

1

Finland Verts/ALE

For (1)

1

Denmark Verts/ALE

2

Netherlands Verts/ALE

2

Latvia Verts/ALE

1

Luxembourg Verts/ALE

For (1)

1

Estonia Verts/ALE

For (1)

1
icon: ECR ECR
42

Hungary ECR

For (1)

1

Belgium ECR

For (1)

1

Denmark ECR

For (1)

1

Netherlands ECR

For (1)

1

Latvia ECR

For (1)

1
icon: EFD EFD
24

United Kingdom EFD

Abstain (1)

5

Greece EFD

2

Belgium EFD

For (1)

1

Slovakia EFD

For (1)

1

Finland EFD

For (1)

1

Denmark EFD

1

Netherlands EFD

For (1)

1

Lithuania EFD

Abstain (1)

1
icon: ALDE ALDE
69

Spain ALDE

1

Greece ALDE

1

Sweden ALDE

Against (1)

3
4

Finland ALDE

Abstain (1)

3

Denmark ALDE

3

Ireland ALDE

3

Slovenia ALDE

For (1)

Abstain (1)

2

Latvia ALDE

Abstain (1)

1

Lithuania ALDE

Abstain (1)

1

Luxembourg ALDE

Abstain (1)

1

Estonia ALDE

1
icon: GUE/NGL GUE/NGL
31

Spain GUE/NGL

Abstain (1)

1

United Kingdom GUE/NGL

Abstain (1)

1
4

Sweden GUE/NGL

Abstain (1)

1

Denmark GUE/NGL

1

Ireland GUE/NGL

Abstain (1)

1

Netherlands GUE/NGL

1

Latvia GUE/NGL

Abstain (1)

1

Cyprus GUE/NGL

Abstain (1)

1
icon: NI NI
20

France NI

Abstain (1)

1

Spain NI

1

United Kingdom NI

For (1)

3

Romania NI

2

Hungary NI

2

Belgium NI

For (1)

1

Bulgaria NI

2
AmendmentsDossier
110 2011/2193(INI)
2012/04/11 JURI 11 amendments...
source: PE-486.137
2012/05/14 ENVI 99 amendments...
source: PE-489.459

History

(these mark the time of scraping, not the official date of the change)

committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
rapporteur
name: YANNAKOUDAKIS Marina date: 2011-09-20T00:00:00 group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
2011-09-20T00:00:00
rapporteur
name: YANNAKOUDAKIS Marina group: European Conservatives and Reformists abbr: ECR
shadows
committees/3
type
Committee Opinion
body
EP
associated
False
committee_full
Legal Affairs
committee
JURI
rapporteur
name: MAŠTÁLKA Jiří date: 2011-11-21T00:00:00 group: European United Left - Nordic Green Left abbr: GUE/NGL
committees/3
type
Committee Opinion
body
EP
associated
False
committee_full
Legal Affairs
committee
JURI
date
2011-11-21T00:00:00
rapporteur
name: MAŠTÁLKA Jiří group: European United Left - Nordic Green Left abbr: GUE/NGL
docs/0/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf
docs/5/body
EC
events/0/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf
events/3/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2012-223&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-7-2012-0223_EN.html
events/6/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-320
New
http://www.europarl.europa.eu/doceo/document/TA-7-2012-0320_EN.html
activities
  • date: 2011-06-17T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf title: COM(2011)0352 type: Non-legislative basic document published celexid: CELEX:52011DC0352:EN body: EC commission: DG: url: http://ec.europa.eu/dgs/health_consumer/index_en.htm title: Health and Consumers Commissioner: DALLI John type: Non-legislative basic document published
  • date: 2011-09-29T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP shadows: group: PPE name: LIESE Peter group: S&D name: PRODI Vittorio group: ALDE name: RIES Frédérique group: Verts/ALE name: AUKEN Margrete group: GUE/NGL name: MATIAS Marisa responsible: True committee: ENVI date: 2011-09-20T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: ECR name: YANNAKOUDAKIS Marina body: EP responsible: False committee_full: Internal Market and Consumer Protection committee: IMCO body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE body: EP responsible: False committee: JURI date: 2011-11-21T00:00:00 committee_full: Legal Affairs rapporteur: group: GUE/NGL name: MAŠTÁLKA Jiří
  • date: 2012-06-20T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP shadows: group: PPE name: LIESE Peter group: S&D name: PRODI Vittorio group: ALDE name: RIES Frédérique group: Verts/ALE name: AUKEN Margrete group: GUE/NGL name: MATIAS Marisa responsible: True committee: ENVI date: 2011-09-20T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: ECR name: YANNAKOUDAKIS Marina body: EP responsible: False committee_full: Internal Market and Consumer Protection committee: IMCO body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE body: EP responsible: False committee: JURI date: 2011-11-21T00:00:00 committee_full: Legal Affairs rapporteur: group: GUE/NGL name: MAŠTÁLKA Jiří
  • date: 2012-06-29T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2012-223&language=EN type: Committee report tabled for plenary, single reading title: A7-0223/2012 body: EP type: Committee report tabled for plenary, single reading
  • date: 2012-09-10T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20120910&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 2012-09-11T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=21817&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-320 type: Decision by Parliament, 1st reading/single reading title: T7-0320/2012 body: EP type: Results of vote in Parliament
commission
  • body: EC dg: Health and Food Safety commissioner: DALLI John
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Environment, Public Health and Food Safety
committee
ENVI
date
2011-09-20T00:00:00
rapporteur
name: YANNAKOUDAKIS Marina group: European Conservatives and Reformists abbr: ECR
shadows
committees/0
body
EP
shadows
responsible
True
committee
ENVI
date
2011-09-20T00:00:00
committee_full
Environment, Public Health and Food Safety
rapporteur
group: ECR name: YANNAKOUDAKIS Marina
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Industry, Research and Energy
committee
ITRE
opinion
False
committees/1
body
EP
responsible
False
committee_full
Internal Market and Consumer Protection
committee
IMCO
committees/2
type
Committee Opinion
body
EP
associated
False
committee_full
Internal Market and Consumer Protection
committee
IMCO
opinion
False
committees/2
body
EP
responsible
False
committee_full
Industry, Research and Energy
committee
ITRE
committees/3
type
Committee Opinion
body
EP
associated
False
committee_full
Legal Affairs
committee
JURI
date
2011-11-21T00:00:00
rapporteur
name: MAŠTÁLKA Jiří group: European United Left - Nordic Green Left abbr: GUE/NGL
committees/3
body
EP
responsible
False
committee
JURI
date
2011-11-21T00:00:00
committee_full
Legal Affairs
rapporteur
group: GUE/NGL name: MAŠTÁLKA Jiří
docs
  • date: 2011-06-17T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf title: COM(2011)0352 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2011&nu_doc=352 title: EUR-Lex summary: PURPOSE: presentation by the Commission of its Second Report on Voluntary and Unpaid Donation of Tissues and Cells in accordance with Directive 2004/23/EC . CONTENT: the report is based on the Members States' responses to a report template on voluntary and unpaid donation of tissues and cells. All Member States submitted a report to the Commission. In addition, Liechtenstein and Norway submitted a report (in total 29 reporting countries). The report aims to provide an overview of the practice of voluntary and unpaid donation of tissues and cells, focusing on (1) legislative provisions, guidelines and policies; (2) compensation and incentives; (3) promotion and advertising, and (4) procurement and supply. Compliance: the report shows that Member States overall comply with Article 12 of Directive 2004/23/EC, requiring Member States to take the necessary measures to endeavour to ensure voluntary and unpaid donations of tissues and cells. Largely in line with the findings of the first report on voluntary and unpaid donation of tissues and cells (issued in 2006), this report shows that legislative provisions and guidelines on voluntary and unpaid donation of tissues and cells are well established across the EU. 27 out of the 29 reporting countries have such legislative provisions or guidelines in place. Compensation: 19 of the reporting countries have some form of compensation or incentive structures for donors of tissues and cells (excluding reproductive cells), such as reimbursement of travel and medical costs. For reproductive cells, about half of the countries provide some forms of compensation or incentives, including reimbursement of travel costs, refreshments and compensation linked to loss of earnings. In addition, four countries give some form of compensation or incentives to relatives of deceased donors. Promotion: 19 countries have undertaken some form of measures to promote voluntary and unpaid donation of tissues and cells, such as awareness raising and information campaigns. In addition, 23 countries have restrictions or prohibitions on advertising the need for, or availability of, human tissues and cells with a view to offering or seeking financial gain or comparable advantage (in line with article 12 of Directive 2004/23/EC). Procurement and supply of tissues and cells : the report shows that the majority of the countries have public collectors/suppliers or a dual system of public and private collectors/suppliers. With regards to supply, 11 countries report having policies in place to endeavour to promote self-sufficiency of tissues and cells, and 17 countries have bilateral or other forms of agreements/collaboration structures to ensure national supply of tissues and cells. However, almost half of the countries report some form of shortages of tissues and cells, including bone marrow and gametes. As set out in Article 12 of Directive 2004/23/EC, the Commission shall inform the European Parliament and the Council of any necessary further measures it intends to take in the field of voluntary and unpaid donation of tissues and cells. Based on the findings of this report, the Commission will now, together with the Member States, reflect on the potential need for further measures, keeping in mind that the Commission's legal mandate is limited to quality and safety of tissues and cells. type: Follow-up document body: EC
  • date: 2012-03-09T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE480.608 title: PE480.608 type: Committee draft report body: EP
  • date: 2012-04-26T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE478.552&secondRef=02 title: PE478.552 committee: JURI type: Committee opinion body: EP
  • date: 2012-05-15T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE489.459 title: PE489.459 type: Amendments tabled in committee body: EP
  • date: 2012-06-07T00:00:00 docs: title: PE491.173 type: Amendments tabled in committee body: EP
  • date: 2012-12-19T00:00:00 docs: url: /oeil/spdoc.do?i=21817&j=0&l=en title: SP(2012)766 type: Commission response to text adopted in plenary
events
  • date: 2011-06-17T00:00:00 type: Non-legislative basic document published body: EC docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf title: COM(2011)0352 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2011&nu_doc=352 title: EUR-Lex summary: The Commission presents its Second Report on Voluntary and Unpaid Donation of Tissues and Cells in accordance with Directive 2004/23/EC . The report is based on the Members States' responses to a report template on voluntary and unpaid donation of tissues and cells. All Member States submitted a report to the Commission. In addition, Liechtenstein and Norway submitted a report (in total 29 reporting countries). The report aims to provide an overview of the practice of voluntary and unpaid donation of tissues and cells, focusing on 1) legislative provisions, guidelines and policies; 2) compensation and incentives; 3) promotion and advertising, and 4) procurement and supply. Compliance: the report shows that Member States overall comply with Article 12 of Directive 2004/23/EC, requiring Member States to take the necessary measures to endeavour to ensure voluntary and unpaid donations of tissues and cells. Largely in line with the findings of the first report on voluntary and unpaid donation of tissues and cells (issued in 2006), this report shows that legislative provisions and guidelines on voluntary and unpaid donation of tissues and cells are well established across the EU. 27 out of the 29 reporting countries have such legislative provisions or guidelines in place. Compensation: 19 of the reporting countries have some form of compensation or incentive structures for donors of tissues and cells (excluding reproductive cells), such as reimbursement of travel and medical costs. For reproductive cells, about half of the countries provide some forms of compensation or incentives, including reimbursement of travel costs, refreshments and compensation linked to loss of earnings. In addition, four countries give some form of compensation or incentives to relatives of deceased donors. Promotion: 19 countries have undertaken some form of measures to promote voluntary and unpaid donation of tissues and cells, such as awareness raising and information campaigns. In addition, 23 countries have restrictions or prohibitions on advertising the need for, or availability of, human tissues and cells with a view to offering or seeking financial gain or comparable advantage (in line with article 12 of Directive 2004/23/EC). Procurement and supply of tissues and cells : the report shows that the majority of the countries have public collectors/suppliers or a dual system of public and private collectors/suppliers. With regards to supply, 11 countries report having policies in place to endeavour to promote self-sufficiency of tissues and cells, and 17 countries have bilateral or other forms of agreements/collaboration structures to ensure national supply of tissues and cells. However, almost half of the countries report some form of shortages of tissues and cells, including bone marrow and gametes. As set out in Article 12 of Directive 2004/23/EC, the Commission shall inform the European Parliament and the Council of any necessary further measures it intends to take in the field of voluntary and unpaid donation of tissues and cells. Based on the findings of this report, the Commission will now, together with the Member States, reflect on the potential need for further measures, keeping in mind that the Commission's legal mandate is limited to quality and safety of tissues and cells.
  • date: 2011-09-29T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 2012-06-20T00:00:00 type: Vote in committee, 1st reading/single reading body: EP
  • date: 2012-06-29T00:00:00 type: Committee report tabled for plenary, single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2012-223&language=EN title: A7-0223/2012 summary: The Committee on the Environment, Public Health and Food Safety adopted the own-initiative report by Marina YANNAKOUDAKIS (ECR, UK) on voluntary and unpaid donation of tissues and cells in response to the Second Report from the Commission on the subject. It notes with concern that half of Member States state that they regularly face a lack of human tissues and cells, particularly spinal marrow, gametes and tissues such as corneas and skin; believes that the policies and laws in force should therefore be reviewed, as they are not adequate to meet the challenge of self-sufficiency in the European Union. Members recall that while 11 countries have official policies in place to endeavour to promote self-sufficiency of tissues and cells, 17 other countries have bilateral agreements with the same aim of ensuring national supplies of human tissues and cells. Non-remuneration, consent and safeguarding health : the report states that the removal of tissue and cells must be subject to the following principles: anonymity (except in the case of removal from a living person for a relative), non-remuneration, consent, the obligation to share organs for transplant fairly among patients, and safeguarding the health of donors and recipients. Members go on to stress that donation should be voluntary, unpaid and anonymous (except in the case of procurement from a living person for a relative), governed by protective legal and ethical rules that respect the integrity of the person. They call on the Commission to · report on current national practices and criteria for compensation of living donors, especially as regards egg cell donation; · carefully monitor developments in the Member States, to examine carefully any reports from civil society or in the media about violation of the principle of unpaid donation, and to take appropriate action, including, if necessary, infringement proceedings. Member States are asked to clearly define the conditions under which fair and proportionate financial compensation may be granted, bearing in mind that compensation is strictly limited to conditions making good the expenses incurred in donating tissues and cells, such as travel expenses, loss of earnings or medical costs related to the medical procedure and possible side effects, thereby prohibiting any financial incentives and avoiding disadvantages for a potential donor. Such compensations must be transparent and regularly audited. Any compensation provided to donors must be compatible with ethical principles. The committee advises that particular attention should be paid to this issue where the compensation is given not to the donor, but to the donor’s family after death. Four countries provide forms of compensation or incentives to relatives of deceased donors; Anonymity, traceability, transparency and information: the committee calls on all Member States to: · set up rules for ensuring the traceability of tissues and cells of human origin from donor to patient and vice versa, as well as a system for the regulation of imports of human tissues and cells from third countries, ensuring that equivalent standards of quality and safety will apply. · step up their public information and awareness-raising campaigns to promote the donation of tissues and cells and to ensure the provision of medical information that is clear, fair, scientifically based and conclusive and of data enabling the public to make informed choices; · take coordinated actions to prevent the development of a black market in gametes on the Internet, as such a market risks both undermining the quality and safety of tissues and cells and raises legal, ethical and public health problems. Exchanging best practice and reinforcing European and international cooperation : the report calls on Member States to step up exchanges of good practices, particularly with regard to the supply of tissues and cells, the protection of the quality of tissues and cells while they are being transported, raising awareness of donating and training health staff. The Commission and Member States should consider the possibility of setting up a Europe-wide database of donors and potential recipients in order to manage supply in the general interest and avoid shortages where possible. Members particularly applaud the role in this field of Eurocet, which has played a crucial role in acting as the central European database for the collection of data on tissue and cell donation and transplantation activities. They call on Member State authorities to reinforce their collaboration with Eurocet in order to agree further common standards in the donation of cells and tissues and thereby enable healthcare professionals to improve the matches offered to European citizens. Cord blood and stem cells : Members recognise the significant scientific advances made in the cord blood field, which is a very promising therapeutic alternative in the treatment of many diseases, including children’s illnesses. They call therefore on the Commission and Member States to take appropriate measures to establish a regulatory framework which could stimulate increased availability of umbilical cord blood stem cells. The committee regrets that at present, stem cells from umbilical cord blood are only stored at 1% of total births in the EU. Member States are asked to raise awareness of public cord blood banking through information campaigns that may take place, for example, during antenatal classes, and proposes that in compliance with the provisions of the Charter of Fundamental Rights of the European Union. Furthermore, comprehensive, objective and accurate information should be provided about the advantages and disadvantages of cord blood banks. The report proposes that Member States consider adopting and enforcing operational and ethical standards for public and private cord blood banks that uphold the principle of non-commercialisation of the human body and its parts, for example, and ensure traceability. It expects all Member States to establish at least one public stem cell bank, and calls for European standards and requirements for private stem cell banks. Members note that collaboration models and opportunities between public and private sectors already exist in some Member States, and they encourage public and private cord blood banks to collaborate closely in order to increase the availability and exchange of national, European and international cord blood and tissue samples. They call on Member States to appropriately regulate both public and private banks to guarantee the fullest transparency and safety of cord blood, and also highlight the development of non-intrusive procedures of harvesting stem cells using peripheral blood stem cell collection (PBSC). Whilst emphasising that it is for the Member States to decide whether to allow, prohibit or regulate research with human embryonic stem cells and in vitro fertilization, Member States must respect the rules set out in Directive 2004/23/EC, The Commission is asked to: · propose a revision of Directive 2004/23/EC in order to bring it into line with the principles governing organ donation laid down in Directive 2010/45/EU, and to take into account the new legal situation after the entry into force of the Lisbon Treaty, scientific developments, the practical experience of those involved in the sector and the recommendations of this report; · propose a revision of Regulation (EC) No 1394/2007 in order to include a provision that guarantees the application of the principle of unpaid donation similar to that referred to in Directive 2010/45/EU and to take into account the problems that have occurred in respect of the implementation of the regulation, especially for SMEs.
  • date: 2012-09-10T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20120910&type=CRE title: Debate in Parliament
  • date: 2012-09-11T00:00:00 type: Results of vote in Parliament body: EP docs: url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=21817&l=en title: Results of vote in Parliament
  • date: 2012-09-11T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-320 title: T7-0320/2012 summary: The European Parliament adopted by 551 votes to 15, with 81 abstentions, a resolution on voluntary and unpaid donation of tissues and cells in response to the Second Report from the Commission on the subject. It notes with concern that half of Member States state that they regularly face a lack of human tissues and cells , particularly spinal marrow, gametes and tissues such as corneas and skin; believes that the policies and laws in force should therefore be reviewed, as they are not adequate to meet the challenge of self-sufficiency in the EU. Members recall that while 11 countries have official policies in place to endeavour to promote self-sufficiency of tissues and cells, 17 other countries have bilateral agreements with the same aim of ensuring national supplies of human tissues and cells. Non-remuneration, consent and safeguarding health: the resolution states that the removal of tissue and cells must be subject to the following principles: anonymity (except in the case of removal from a living person for a relative), non-remuneration, consent, the obligation to share organs for transplant fairly among patients, and safeguarding the health of donors and recipients. Parliament calls on Member States to adopt protective measures for living donors and to guarantee that donation is anonymous (except in the case of procurement from a living person for a relative), voluntary, freely agreed to, informed and not remunerated. It calls on the Commission to report on current national practices and criteria for compensation of living donors, especially as regards egg cell donation; carefully monitor developments in the Member States, to examine carefully any reports from civil society or in the media about violation of the principle of unpaid donation , and to take appropriate action, including, if necessary, infringement proceedings. Member States are asked to clearly define the conditions under which fair and proportionate financial compensation may be granted, bearing in mind that compensation is strictly limited to conditions making good the expenses incurred in donating tissues and cells, such as travel expenses, loss of earnings or medical costs related to the medical procedure and possible side effects, thereby prohibiting any financial incentives and avoiding disadvantages for a potential donor. Such compensations must be transparent and regularly audited. Any compensation provided to donors must be compatible with ethical principles. The committee advises that particular attention should be paid to this issue where the compensation is given not to the donor, but to the donor’s family after death . Four countries provide forms of compensation or incentives to relatives of deceased donors. Anonymity, traceability, transparency and information: Parliament calls on all Member States to: set up rules for ensuring the traceability of tissues and cells of human origin from donor to patient and vice versa, as well as a system for the regulation of imports of human tissues and cells from third countries, ensuring that equivalent standards of quality and safety will apply. step up their public information and awareness-raising campaigns to promote the donation of tissues and cells and to ensure the provision of medical information that is clear, fair, scientifically based and conclusive and of data enabling the public to make informed choices; take coordinated actions to prevent the development of a black market in gametes on the Internet, as such a market risks both undermining the quality and safety of tissues and cells and raises legal, ethical and public health problems. Exchanging best practice and reinforcing European and international cooperation: Parliament calls on Member States to step up exchanges of good practices, particularly with regard to the supply of tissues and cells, the protection of the quality of tissues and cells while they are being transported, raising awareness of donating and training health staff. The Commission and Member States should consider the possibility of setting up a Europe-wide database of donors and potential recipients in order to manage supply in the general interest and avoid shortages where possible. Members particularly applaud the role in this field of Eurocet, which has played a crucial role in acting as the central European database for the collection of data on tissue and cell donation and transplantation activities. They call on Member State authorities to reinforce their collaboration with Eurocet in order to agree further common standards in the donation of cells and tissues and thereby enable healthcare professionals to improve the matches offered to European citizens. Cord blood and stem cells: Members recognise the significant scientific advances made in the cord blood field, which is a very promising therapeutic alternative in the treatment of many diseases, including children’s illnesses. They call therefore on the Commission and Member States to take appropriate measures to establish a regulatory framework which could stimulate increased availability of umbilical cord blood stem cells. Parliament regrets that at present, stem cells from umbilical cord blood are only stored at 1% of total births in the EU. Member States are asked to raise awareness of public cord blood banking through information campaigns that may take place, for example, during antenatal classes, and proposes that in compliance with the provisions of the Charter of Fundamental Rights of the European Union. Parliament takes the view that donations of non-family allogeneic umbilical cord blood, regardless of whether the bank is public or private, should be further developed, so that stored units of umbilical cord blood are registered in the Bone Marrow Donors Worldwide (BMDW) database and made available to any compatible patient who needs them. Furthermore, comprehensive, objective and accurate information should be provided about the advantages and disadvantages of cord blood banks. Parliament proposes that Member States consider adopting and enforcing operational and ethical standards for public and private cord blood banks that uphold the principle of non-commercialisation of the human body and its parts, for example, and ensure traceability. It expects all Member States to establish at least one public stem cell bank, and calls for European standards and requirements for private stem cell banks . Member States are further asked to provide a territorial network of maternity centres authorised to carry out this procurement to guarantee cord blood supply in all population centres. Members note that collaboration models and opportunities between public and private sectors already exist in some Member States, and they encourage public and private cord blood banks to collaborate closely in order to increase the availability and exchange of national, European and international cord blood and tissue samples. They call on Member States to appropriately regulate both public and private banks to guarantee the fullest transparency and safety of cord blood, and also highlight the development of non-intrusive procedures of harvesting stem cells using peripheral blood stem cell collection (PBSC). Whilst emphasising that it is for the Member States to decide whether to allow, prohibit or regulate research with human embryonic stem cells and in vitro fertilization, Parliament notes that Member States must respect the rules set out in Directive 2004/23/EC. It points out that the EU has limited competence in this area and, when applying this competence, needs to respect the principles of the EU Charter of Fundamental Rights and the principles applied in the judgments of the Court of Justice. The Commission is asked to: propose a revision of Directive 2004/23/EC in order to bring it into line with the principles governing organ donation laid down in Directive 2010/45/EU, and to take into account the new legal situation after the entry into force of the Lisbon Treaty, scientific developments, the practical experience of those involved in the sector and the recommendations of this resolution; propose a revision of Regulation (EC) No 1394/2007 in order to include a provision that guarantees the application of the principle of unpaid donation similar to that referred to in Directive 2010/45/EU and to take into account the problems that have occurred in respect of the implementation of the Regulation, especially for SMEs.
  • date: 2012-09-11T00:00:00 type: End of procedure in Parliament body: EP
links
other
  • body: EC dg: url: http://ec.europa.eu/dgs/health_consumer/index_en.htm title: Health and Consumers commissioner: DALLI John
procedure/Modified legal basis
Old
Rules of Procedure of the European Parliament EP 150
New
Rules of Procedure EP 150
procedure/dossier_of_the_committee
Old
ENVI/7/06547
New
  • ENVI/7/06547
procedure/legal_basis/0
Rules of Procedure EP 052
procedure/legal_basis/0
Rules of Procedure of the European Parliament EP 052
procedure/subject
Old
  • 4.20.01 Medicine, diseases
  • 4.20.02 Medical research
  • 4.20.05 Health legislation and policy
New
4.20.01
Medicine, diseases
4.20.02
Medical research
4.20.05
Health legislation and policy
activities/0/docs/0/celexid
CELEX:52011DC0352:EN
activities/0/docs/0/celexid
CELEX:52011DC0352:EN
activities
  • date: 2011-06-17T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2011/0352/COM_COM(2011)0352_EN.pdf title: COM(2011)0352 type: Non-legislative basic document published celexid: CELEX:52011DC0352:EN body: EC type: Non-legislative basic document published commission: DG: url: http://ec.europa.eu/dgs/health_consumer/index_en.htm title: Health and Consumers Commissioner: DALLI John
  • date: 2011-09-29T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP shadows: group: PPE name: LIESE Peter group: S&D name: PRODI Vittorio group: ALDE name: RIES Frédérique group: Verts/ALE name: AUKEN Margrete group: GUE/NGL name: MATIAS Marisa responsible: True committee: ENVI date: 2011-09-20T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: ECR name: YANNAKOUDAKIS Marina body: EP responsible: False committee_full: Internal Market and Consumer Protection committee: IMCO body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE body: EP responsible: False committee: JURI date: 2011-11-21T00:00:00 committee_full: Legal Affairs rapporteur: group: GUE/NGL name: MAŠTÁLKA Jiří
  • date: 2012-06-20T00:00:00 body: EP type: Vote in committee, 1st reading/single reading committees: body: EP shadows: group: PPE name: LIESE Peter group: S&D name: PRODI Vittorio group: ALDE name: RIES Frédérique group: Verts/ALE name: AUKEN Margrete group: GUE/NGL name: MATIAS Marisa responsible: True committee: ENVI date: 2011-09-20T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: ECR name: YANNAKOUDAKIS Marina body: EP responsible: False committee_full: Internal Market and Consumer Protection committee: IMCO body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE body: EP responsible: False committee: JURI date: 2011-11-21T00:00:00 committee_full: Legal Affairs rapporteur: group: GUE/NGL name: MAŠTÁLKA Jiří
  • date: 2012-06-29T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2012-223&language=EN type: Committee report tabled for plenary, single reading title: A7-0223/2012 body: EP type: Committee report tabled for plenary, single reading
  • date: 2012-09-10T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20120910&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 2012-09-11T00:00:00 docs: url: http://www.europarl.europa.eu/oeil/popups/sda.do?id=21817&l=en type: Results of vote in Parliament title: Results of vote in Parliament url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-TA-2012-320 type: Decision by Parliament, 1st reading/single reading title: T7-0320/2012 body: EP type: Results of vote in Parliament
committees
  • body: EP shadows: group: PPE name: LIESE Peter group: S&D name: PRODI Vittorio group: ALDE name: RIES Frédérique group: Verts/ALE name: AUKEN Margrete group: GUE/NGL name: MATIAS Marisa responsible: True committee: ENVI date: 2011-09-20T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: ECR name: YANNAKOUDAKIS Marina
  • body: EP responsible: False committee_full: Internal Market and Consumer Protection committee: IMCO
  • body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE
  • body: EP responsible: False committee: JURI date: 2011-11-21T00:00:00 committee_full: Legal Affairs rapporteur: group: GUE/NGL name: MAŠTÁLKA Jiří
links
other
  • body: EC dg: url: http://ec.europa.eu/dgs/health_consumer/index_en.htm title: Health and Consumers commissioner: DALLI John
procedure
dossier_of_the_committee
ENVI/7/06547
reference
2011/2193(INI)
title
Voluntary and unpaid donation of tissues and cells
legal_basis
Rules of Procedure of the European Parliament EP 052
stage_reached
Procedure completed
subtype
Initiative
Modified legal basis
Rules of Procedure of the European Parliament EP 150
type
INI - Own-initiative procedure
subject